Publications by authors named "Edmund P. Harrigan"

4Publications

The tolerability of intramuscular ziprasidone and haloperidol treatment and the transition to oral therapy.

Authors:
David G Daniel Dan L Zimbroff Rachel H Swift Edmund P Harrigan

Int Clin Psychopharmacol 2004 Jan;19(1):9-15

Bioniche Development Inc., McLean, Virginia, USA.

View Article and Find Full Text PDF
January 2004

A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition.

Authors:
Edmund P Harrigan Jeffrey J Miceli Richard Anziano Eric Watsky Karen R Reeves Neal R Cutler John Sramek Thomas Shiovitz Michelle Middle

J Clin Psychopharmacol 2004 Feb;24(1):62-9

Pfizer Global Research and Development, New London, CT 06320, USA.

View Article and Find Full Text PDF
February 2004

Torsades de pointes associated with nonantiarrhythmic drugs and observations on gender and QTc.

Authors:
Martin M Bednar Edmund P Harrigan Jeremy N Ruskin

Am J Cardiol 2002 Jun;89(11):1316-9

Pfizer Global Research and Development, Groton, Connecticut, USA.

View Article and Find Full Text PDF
June 2002

Pharmacokinetics of a New Anticonvulsant (CGP 33101) in Epileptic Male Patients and Healthy Male Subjects after Single Ascending Oral Doses of 400--1200 mg.

Authors:
Linda A. Brunner Edmund P. Harrigan Vivian A. John Mark L. Powell

Am J Ther 1994 Oct;1(3):215-220

Research Department, Pharmaceuticals Division Ciba-Geigy Corporation, Ardsley, NY 10502 USA.

View Article and Find Full Text PDF
October 1994